SD HEALTHCARE

MappBio Wins Contract To Combat Viruses

San Diego’s MappBio recently received a $14.8 million contract to advance a treatment for Sudan virus.

Ligand Pharmaceuticals Closes Acquisition of Vernalis

San Diego-based Ligand Pharmaceuticals closed its acquisition of Vernalis Plc in a deal that Ligand said will add “shots on goal” to its portfolio.

Scripps Research Adds Board of Overseers

Scripps Research added a 21-member Board of Overseers with big names from across San Diego life sciences as the organization broadens its scope, it was recently announced.

UC San Diego to Open New Rancho Bernardo Facility

UC San Diego Health on Oct. 15 will open a 57,000-square-foot Rancho Bernardo center with offerings spanning primary care, urgent care and behavioral health.

Sharp Grossmont Hospital’s Burr Heart & Vascular Center Opens

Burr Heart & Vascular Center at Sharp Grossmont Hospital – per Sharp the only dedicated cardiovascular center in East County -- recently began treating patients.

With Eye On Expansion, Co. Consolidates Its Diverse Pharma Forces

Japanese food and drug manufacturing giant Ajinomoto Group is reorganizing, placing three disparate drug-making businesses on three continents under one umbrella.

Tease photo

Leidos to Support Navy Health Research in $58M Deal

Leidos Inc. recently received a five-year, $57.8 million task order to perform work at Naval Health Research Center in San Diego.

With Drug Approval, Ionis Set to Compete with Alnylam

The U.S. Food and Drug Administration on Oct. 5 approved Ionis Pharmaceuticals’ drug for a potentially fatal genetic disorder, pitting the company against Alnylam Pharmaceuticals.

S.D. Sustainable Chemical Manufacturer Raises $90M

Genomatica, which manufactures plant-based chemicals, raised $90 million in an equity offering.

Tease photo

Biotechs Among Most Impacted by Gender Law

LEGAL: Women Often Bypassed On Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Tease photo

Medtechs Lead Life Science Stock Gains for Third Quarter

Medtechs led the way in stocks of public life science companies in San Diego during the third quarter.

Tease photo

MappBio Awarded $14.8M Contract for Sudan Virus Therapy

San Diego’s MappBio received a $14.8 million contract to advance a treatment for Sudan virus.

Biotechs Among Most Impacted by Law Requiring Women on Boards

LEGAL: Dearth of Women on Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Frances Arnold, an Illumina Board Member, Shares Nobel Prize

The board director of San Diego life sciences giant Illumina and professor at Caltech shared in the Nobel Prize for Chemistry.

Tease photo

Acadia and FDA Confident in Parkinson’s Psychosis Drug

Acadia Pharmaceuticals is flying higher after the U.S. Food and Drug Administration reaffirmed its drug in uncharacteristically public fashion.